ImmCancer - Portal for cancer immunothrerapy tools and repositories
Cite : Dhall et al. (2021) In silico tools and databases for designing cancer immunotherapy. Advances in Protein Chemistry and Structural Biology doi.org/10.1016/bs.apcsb.2021.11.008
The computational tools and resources integrate the cancer patient's genomic, transcriptomic, and mutation profiles for better treatment. Of note, NGS pipelines and bioinformatics methodologies play a significant role in the development of personalized therapies, HLA-peptide binding prediction, and neoantigen predictions. ImmCancer enlists several public repositories and in silico tools generated to analyze and predict the wide range of genomic data for the designing of cancer immunotherapies.